SCHEMBL2228082

SCHEMBL2228082

CN1CCN(C)C1=[N]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17055584 0.64 INMT (0.32)
SCHEMBL1177147 0.61
SCHEMBL3043 0.61
SCHEMBL13265156 0.61 INMT (0.30)
SCHEMBL9945748 0.61
SCHEMBL8644481 0.61
SCHEMBL2398125 0.61 BRD4 (0.43)
SCHEMBL13238885 0.61 INMT (0.30)
SCHEMBL717518 0.61 BRD4 (0.43)
Fluoride SCHEMBL6368967 0.59 BRD4 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124607-A1 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC 2005-06-09 US claimed
US-20140030182-A1 CARBON FILMS PRODUCED FROM IONIC LIQUID CARBON PRECURSORS UT-BATTELLE, LLC (US) 2014-01-30 US disclosed
US-8574534-B2 Carbon films produced from ionic liquid carbon precursors UT-BATTELLE, LLC (US) 2013-11-05 US disclosed
US-8524388-B2 Superbase-derived protic ionic liquids UT-BATTELLE, LLC (US) 2013-09-03 US disclosed
US-20110229401-A1 Carbon Films Produced from Ionic Liquid Carbon Precursors UT-BATTELLE, LLC (US) 2011-09-22 US disclosed
US-20110177428-A1 Superbase-Derived Protic Ionic Liquids UT-BATTELLE, LLC (US) 2011-07-21 US disclosed
EP-1644343-B1 5-SUBSTITUTED QUINAZOLINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-07-04 EP disclosed
EP-1644343-A1 5-SUBSTITUTED QUINAZOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-04-12 EP disclosed
US-20050124607-A1 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC 2005-06-09 US disclosed
WO-2005005397-A1 5-SUBSTITUTED QUINAZOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-01-20 WO disclosed